Iridocyclitis associated with angle-supported phakic intraocular lenses
Identifieur interne : 000824 ( PascalFrancis/Curation ); précédent : 000823; suivant : 000825Iridocyclitis associated with angle-supported phakic intraocular lenses
Auteurs : Antonio Leccisotti [Italie]Source :
- Journal of cataract and refractive surgery [ 0886-3350 ] ; 2006.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Association, Chirurgie.
English descriptors
- KwdEn :
Abstract
PURPOSE: To evaluate incidence, features, risk factors, and prognosis of iridocyclitis after angle-supported phakic intraocular lens (IOL) implantation. SETTING: Private practice, Siena, Italy. METHODS: This retrospective analysis comprised 356 consecutive eyes of 212 patients. In myopic eyes, the ZSAL-4 IOL (205 eyes of 125 patients) or the ZSAL-4 Plus IOL (106 eyes of 63 patients) was used. In hyperopic eyes (45 eyes of 24 patients), the Type 54 IOL was implanted. Haptic posterior angulation was 19 degrees (ZSAL-4), 23 degrees (ZSAL-4 Plus), and 14 degrees (Type 54). RESULTS: Clinically significant iridocyclitis occurred in 11 eyes (3.1%) of 11 patients. Mean patient age was 37.3 years ± 9.4 (SD). Sixty-four percent were male (odds ratio [OR], 3.0; 95% confidence interval [Cl], 0.8 to 7.4, not statistically significant). Iridocyclitis was observed in 4.4% of hyperopic eyes (OR, 1.6; 95% Cl, 0.3 to 7.4; not statistically significant) and in 2.9% of myopic eyes. In myopic eyes, it followed the implantation of ZSAL-4 IOL in 3.9% of eyes (OR, 4.1; 95% Cl, 0.5 to 33.6; not statistically significant), and of ZSAL-4 Plus IOL in 1%. Mean time from surgery was 8.5 + 10.6 months). Presentation included aqueous flare (100%), posterior synechiae (82%), blurred vision (82%), redness (36%), pain (27%), IOL precipitates (18%), and angular synechiae (9%). Only 1 patient had recurrences, leading to IOL explantation and cataract surgery. After topical therapy, best spectacle-corrected visual acuity was fully recovered in 9 of 11 eyes. CONCLUSION: Iridocyclitis can occur months or years after the implantation of angle-supported phakic lOLs. No statistically significant risk factors were identified. Functional prognosis is generally good.
| pA |
|
|---|
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000C82
Links to Exploration step
Pascal:06-0360057Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Iridocyclitis associated with angle-supported phakic intraocular lenses</title><author><name sortKey="Leccisotti, Antonio" sort="Leccisotti, Antonio" uniqKey="Leccisotti A" first="Antonio" last="Leccisotti">Antonio Leccisotti</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Ophthalmic Surgery Unit, Casa di Cura Rugani</s1><s2>Siena</s2><s3>ITA</s3><sZ>1 aut.</sZ></inist:fA14><country>Italie</country></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">06-0360057</idno><date when="2006">2006</date><idno type="stanalyst">PASCAL 06-0360057 INIST</idno><idno type="RBID">Pascal:06-0360057</idno><idno type="wicri:Area/PascalFrancis/Corpus">000C82</idno><idno type="wicri:Area/PascalFrancis/Curation">000824</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Iridocyclitis associated with angle-supported phakic intraocular lenses</title><author><name sortKey="Leccisotti, Antonio" sort="Leccisotti, Antonio" uniqKey="Leccisotti A" first="Antonio" last="Leccisotti">Antonio Leccisotti</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Ophthalmic Surgery Unit, Casa di Cura Rugani</s1><s2>Siena</s2><s3>ITA</s3><sZ>1 aut.</sZ></inist:fA14><country>Italie</country></affiliation></author></analytic><series><title level="j" type="main">Journal of cataract and refractive surgery</title><title level="j" type="abbreviated">J. cataract refractive surg.</title><idno type="ISSN">0886-3350</idno><imprint><date when="2006">2006</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">Journal of cataract and refractive surgery</title><title level="j" type="abbreviated">J. cataract refractive surg.</title><idno type="ISSN">0886-3350</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Angle</term><term>Association</term><term>Intraocular lens</term><term>Iridocyclitis</term><term>Ophthalmology</term><term>Support</term><term>Surgery</term><term>Treatment</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Iridocyclite</term><term>Association</term><term>Angle</term><term>Support</term><term>Lentille intraoculaire</term><term>Chirurgie</term><term>Ophtalmologie</term><term>Traitement</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Association</term><term>Chirurgie</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">PURPOSE: To evaluate incidence, features, risk factors, and prognosis of iridocyclitis after angle-supported phakic intraocular lens (IOL) implantation. SETTING: Private practice, Siena, Italy. METHODS: This retrospective analysis comprised 356 consecutive eyes of 212 patients. In myopic eyes, the ZSAL-4 IOL (205 eyes of 125 patients) or the ZSAL-4 Plus IOL (106 eyes of 63 patients) was used. In hyperopic eyes (45 eyes of 24 patients), the Type 54 IOL was implanted. Haptic posterior angulation was 19 degrees (ZSAL-4), 23 degrees (ZSAL-4 Plus), and 14 degrees (Type 54). RESULTS: Clinically significant iridocyclitis occurred in 11 eyes (3.1%) of 11 patients. Mean patient age was 37.3 years ± 9.4 (SD). Sixty-four percent were male (odds ratio [OR], 3.0; 95% confidence interval [Cl], 0.8 to 7.4, not statistically significant). Iridocyclitis was observed in 4.4% of hyperopic eyes (OR, 1.6; 95% Cl, 0.3 to 7.4; not statistically significant) and in 2.9% of myopic eyes. In myopic eyes, it followed the implantation of ZSAL-4 IOL in 3.9% of eyes (OR, 4.1; 95% Cl, 0.5 to 33.6; not statistically significant), and of ZSAL-4 Plus IOL in 1%. Mean time from surgery was 8.5 + 10.6 months). Presentation included aqueous flare (100%), posterior synechiae (82%), blurred vision (82%), redness (36%), pain (27%), IOL precipitates (18%), and angular synechiae (9%). Only 1 patient had recurrences, leading to IOL explantation and cataract surgery. After topical therapy, best spectacle-corrected visual acuity was fully recovered in 9 of 11 eyes. CONCLUSION: Iridocyclitis can occur months or years after the implantation of angle-supported phakic lOLs. No statistically significant risk factors were identified. Functional prognosis is generally good.</div></front></TEI><inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0886-3350</s0></fA01><fA02 i1="01"><s0>JCSUEV</s0></fA02><fA03 i2="1"><s0>J. cataract refractive surg.</s0></fA03><fA05><s2>32</s2></fA05><fA06><s2>6</s2></fA06><fA08 i1="01" i2="1" l="ENG"><s1>Iridocyclitis associated with angle-supported phakic intraocular lenses</s1></fA08><fA11 i1="01" i2="1"><s1>LECCISOTTI (Antonio)</s1></fA11><fA14 i1="01"><s1>Ophthalmic Surgery Unit, Casa di Cura Rugani</s1><s2>Siena</s2><s3>ITA</s3><sZ>1 aut.</sZ></fA14><fA20><s1>1007-1010</s1></fA20><fA21><s1>2006</s1></fA21><fA23 i1="01"><s0>ENG</s0></fA23><fA43 i1="01"><s1>INIST</s1><s2>20937</s2><s5>354000138954620150</s5></fA43><fA44><s0>0000</s0><s1>© 2006 INIST-CNRS. All rights reserved.</s1></fA44><fA45><s0>21 ref.</s0></fA45><fA47 i1="01" i2="1"><s0>06-0360057</s0></fA47><fA60><s1>P</s1></fA60><fA61><s0>A</s0></fA61><fA64 i1="01" i2="1"><s0>Journal of cataract and refractive surgery</s0></fA64><fA66 i1="01"><s0>USA</s0></fA66><fC01 i1="01" l="ENG"><s0>PURPOSE: To evaluate incidence, features, risk factors, and prognosis of iridocyclitis after angle-supported phakic intraocular lens (IOL) implantation. SETTING: Private practice, Siena, Italy. METHODS: This retrospective analysis comprised 356 consecutive eyes of 212 patients. In myopic eyes, the ZSAL-4 IOL (205 eyes of 125 patients) or the ZSAL-4 Plus IOL (106 eyes of 63 patients) was used. In hyperopic eyes (45 eyes of 24 patients), the Type 54 IOL was implanted. Haptic posterior angulation was 19 degrees (ZSAL-4), 23 degrees (ZSAL-4 Plus), and 14 degrees (Type 54). RESULTS: Clinically significant iridocyclitis occurred in 11 eyes (3.1%) of 11 patients. Mean patient age was 37.3 years ± 9.4 (SD). Sixty-four percent were male (odds ratio [OR], 3.0; 95% confidence interval [Cl], 0.8 to 7.4, not statistically significant). Iridocyclitis was observed in 4.4% of hyperopic eyes (OR, 1.6; 95% Cl, 0.3 to 7.4; not statistically significant) and in 2.9% of myopic eyes. In myopic eyes, it followed the implantation of ZSAL-4 IOL in 3.9% of eyes (OR, 4.1; 95% Cl, 0.5 to 33.6; not statistically significant), and of ZSAL-4 Plus IOL in 1%. Mean time from surgery was 8.5 + 10.6 months). Presentation included aqueous flare (100%), posterior synechiae (82%), blurred vision (82%), redness (36%), pain (27%), IOL precipitates (18%), and angular synechiae (9%). Only 1 patient had recurrences, leading to IOL explantation and cataract surgery. After topical therapy, best spectacle-corrected visual acuity was fully recovered in 9 of 11 eyes. CONCLUSION: Iridocyclitis can occur months or years after the implantation of angle-supported phakic lOLs. No statistically significant risk factors were identified. Functional prognosis is generally good.</s0></fC01><fC02 i1="01" i2="X"><s0>002B25B</s0></fC02><fC02 i1="02" i2="X"><s0>002B09F</s0></fC02><fC03 i1="01" i2="X" l="FRE"><s0>Iridocyclite</s0><s5>01</s5></fC03><fC03 i1="01" i2="X" l="ENG"><s0>Iridocyclitis</s0><s5>01</s5></fC03><fC03 i1="01" i2="X" l="SPA"><s0>Iridociclitis</s0><s5>01</s5></fC03><fC03 i1="02" i2="X" l="FRE"><s0>Association</s0><s5>02</s5></fC03><fC03 i1="02" i2="X" l="ENG"><s0>Association</s0><s5>02</s5></fC03><fC03 i1="02" i2="X" l="SPA"><s0>Asociación</s0><s5>02</s5></fC03><fC03 i1="03" i2="X" l="FRE"><s0>Angle</s0><s5>03</s5></fC03><fC03 i1="03" i2="X" l="ENG"><s0>Angle</s0><s5>03</s5></fC03><fC03 i1="03" i2="X" l="SPA"><s0>Angulo</s0><s5>03</s5></fC03><fC03 i1="04" i2="X" l="FRE"><s0>Support</s0><s5>05</s5></fC03><fC03 i1="04" i2="X" l="ENG"><s0>Support</s0><s5>05</s5></fC03><fC03 i1="04" i2="X" l="SPA"><s0>Soporte</s0><s5>05</s5></fC03><fC03 i1="05" i2="X" l="FRE"><s0>Lentille intraoculaire</s0><s5>06</s5></fC03><fC03 i1="05" i2="X" l="ENG"><s0>Intraocular lens</s0><s5>06</s5></fC03><fC03 i1="05" i2="X" l="SPA"><s0>Lente intraocular</s0><s5>06</s5></fC03><fC03 i1="06" i2="X" l="FRE"><s0>Chirurgie</s0><s5>08</s5></fC03><fC03 i1="06" i2="X" l="ENG"><s0>Surgery</s0><s5>08</s5></fC03><fC03 i1="06" i2="X" l="SPA"><s0>Cirugía</s0><s5>08</s5></fC03><fC03 i1="07" i2="X" l="FRE"><s0>Ophtalmologie</s0><s5>09</s5></fC03><fC03 i1="07" i2="X" l="ENG"><s0>Ophthalmology</s0><s5>09</s5></fC03><fC03 i1="07" i2="X" l="SPA"><s0>Oftalmología</s0><s5>09</s5></fC03><fC03 i1="08" i2="X" l="FRE"><s0>Traitement</s0><s5>25</s5></fC03><fC03 i1="08" i2="X" l="ENG"><s0>Treatment</s0><s5>25</s5></fC03><fC03 i1="08" i2="X" l="SPA"><s0>Tratamiento</s0><s5>25</s5></fC03><fC07 i1="01" i2="X" l="FRE"><s0>Oeil pathologie</s0><s5>37</s5></fC07><fC07 i1="01" i2="X" l="ENG"><s0>Eye disease</s0><s5>37</s5></fC07><fC07 i1="01" i2="X" l="SPA"><s0>Ojo patología</s0><s5>37</s5></fC07><fC07 i1="02" i2="X" l="FRE"><s0>Segment antérieur pathologie</s0><s2>NM</s2><s5>38</s5></fC07><fC07 i1="02" i2="X" l="ENG"><s0>Anterior segment disease</s0><s2>NM</s2><s5>38</s5></fC07><fC07 i1="02" i2="X" l="SPA"><s0>Segmento anterior patología</s0><s2>NM</s2><s5>38</s5></fC07><fC07 i1="03" i2="X" l="FRE"><s0>Uvée pathologie</s0><s5>39</s5></fC07><fC07 i1="03" i2="X" l="ENG"><s0>Uvea disease</s0><s5>39</s5></fC07><fC07 i1="03" i2="X" l="SPA"><s0>Uvea patología</s0><s5>39</s5></fC07><fN21><s1>240</s1></fN21><fN44 i1="01"><s1>OTO</s1></fN44><fN82><s1>OTO</s1></fN82></pA></standard></inist></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Ticri/CIDE/explor/HapticV1/Data/PascalFrancis/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000824 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 000824 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Ticri/CIDE
|area= HapticV1
|flux= PascalFrancis
|étape= Curation
|type= RBID
|clé= Pascal:06-0360057
|texte= Iridocyclitis associated with angle-supported phakic intraocular lenses
}}
| This area was generated with Dilib version V0.6.23. |  |